Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -19.26% | 279.23% | 486.65% | 1,198.19% | 183.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.26% | 279.23% | 486.65% | 1,198.19% | 183.67% |
| Cost of Revenue | -12.16% | 237.78% | 368.69% | 575.45% | 317.62% |
| Gross Profit | -34.74% | 713.39% | 4,582.14% | 514.55% | 66.40% |
| SG&A Expenses | 11.09% | 167.88% | 198.24% | 234.86% | 222.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.10% | 188.93% | 215.71% | 243.82% | 211.63% |
| Operating Income | -11.00% | -164.88% | -193.59% | -225.40% | -212.57% |
| Income Before Tax | -35.64% | -449.05% | -562.88% | -323.35% | -224.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.64% | -449.05% | -562.88% | -323.35% | -224.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.64% | -449.05% | -562.88% | -323.35% | -224.66% |
| EBIT | -11.00% | -164.88% | -193.59% | -225.40% | -212.57% |
| EBITDA | -4.11% | -150.76% | -179.41% | -214.01% | -206.55% |
| EPS Basic | 43.95% | -176.54% | -235.30% | -105.14% | -61.27% |
| Normalized Basic EPS | 47.07% | -158.12% | -241.99% | -107.65% | -68.91% |
| EPS Diluted | 43.95% | -175.04% | -228.40% | -102.51% | -59.52% |
| Normalized Diluted EPS | 47.07% | -158.12% | -241.99% | -107.65% | -68.91% |
| Average Basic Shares Outstanding | 161.86% | 83.14% | 38.15% | 23.18% | 15.21% |
| Average Diluted Shares Outstanding | 161.86% | 83.14% | 38.15% | 23.18% | 15.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
